|

Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

RECRUITINGSponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital
Actively Recruiting
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital
Started2017-06-15
Est. completion2037-06-15
View on ClinicalTrials.gov →

NCT03200379

Summary

To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan

Eligibility

Inclusion Criteria:

1\. Patients who are treated with DAA and have willingness to participate in this registry.

Exclusion Criteria:

Chronic hepatitis C patients who are unwilling to participate in the study and do not provide written informed consent for participation.

Conditions2

Hepatitis C, ChronicLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.